There’s a growing consensus that two of society’s most rampant public health issues – Type II Diabetes and Alzheimer’s disease – are intertwined. It’s not all about clearing plaques anymore: Insulin ...
Dara BioSciences said today it granted exclusive worldwide rights to develop and commercialize its DB959 to T3D Therapeutics, which will reposition the experimental drug to fight Alzheimer’s disease.
RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / April 20, 2021 / T3D Therapeutics, Inc. ("T3D"), a clinical stage drug development company engaged in the development of T3D-959, a new orally administered ...
RESEARCH TRIANGLE PARK, N.C., Oct. 3, 2023 /PRNewswire/ -- T3D Therapeutics, Inc. ("T3D") a clinical stage drug development company engaged in the development of T3D-959, a new orally administered ...
The battle for competitive advantage has led businesses to adopt new the cutting-edge technology, or risk being left behind. Many technologies are now coming into their own as their power and speed ...
Anyone searching for an affordable portable multifunctional 3D printer capable of generating high quality small form factor prints may be interested in the T3D created by a team based in San Francisco ...
A small Research Triangle Park drug developer founded by a former GlaxoSmithKline executive thinks it has a way to fight Alzheimer’s, a disease that has for years frustrated drug developers big and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results